IP Library Granted Patent US 8,865,700
Granted Patent B2
US 8,865,700 · App. 13/721,509 · Granted Oct 21, 2014

Collagen stimulators and their use in the treatment of skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,700
App. No.
13/721,509
Granted
Oct 21, 2014
Kind
B2
Abstract

Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ cosmetic composition comprising novel active agents that enhance collagen production in the skin.

Claims (28)

1. A method for treating wrinkles and/or fine lines on human skin comprising topically applying to an area of the skin in need thereof a composition comprising an effective amount of a compound according to formula I(a):

wherein,

L is a bond or a divalent radical selected from —(C═O)—, —O—(C═O)—, —N(R*)—(C═O)—, —(CH 2 ) k —, —O—(CH 2 ) k —, —N(R*)—(CH 2 ) k —, —(CH 2 ) k —(C═O)—, —(CH 2 ) k —O—(C═O)—, —(CH 2 ) k —N(R*)—(C═O)—, where K is an integer from 1-3;

Q represents a five-membered heterocyclic ring selected from the following:

wherein ε 1 , ε 2 , and ε 3 , are independently selected from N, NH, NR*, S, and O; with the proviso that where the point of attachment is ε 1 , ε 2 , or ε 3 , then that position represents N; and wherein carbon atoms which are not the point of attachment may be optionally substituted with a group R; and wherein the dashed circles indicate that each ring may comprise zero, one, or two double bonds;

R 1 -R 5 are independently selected, at each occurrence, from a group R; wherein R is selected from hydrogen, —F; —Cl; —Br; —I; —OH, —OR*; —NH 2 ; —NHR*; —N(R*) 2 ; —N(R*) 3 + ; —N(R*)—OH; —N(→O)(R*) 2 ; —O—N(R*) 2 ; —N(R*)—O—R*; —N(R*)—N(R*) 2 ; —C═N—R*; —N═C(R*) 2 ; —C═N—N(R*) 2 ; —C(═NR*)—N(R*) 2 ; —SH; —SR*; —CN; —NC; —(C═O)—R*; —CHO; —CO 2 H; —CO 2 —; —CO 2 R*; —(C═O)—S—R*; —O—(C═O)—H; —O—(C═O)—R*; —S—(C═O)—R*; —(C═O)—NH 2 ; —(C═O)—N(R*) 2 ; —(C═O)—NHNH 2 ; —O—(C═O)—NHNH 2 ; —(C═S)—NH 2 ; —(C═S)—N(R*) 2 ; —N(R*)—CHO; —N(R*)—(C═O)—R*; —(C═NR)—O—R*; —O—(C═NR*)—R*, —SCN; —NCS; —NSO; —SSR*; —N(R*)—C(═O)—N(R*) 2 ; —N(R*)—C(═S)—N(R*) 2 ; —SO 2 —R*; —O—S(═O) 2 —R*; —S(═O) 2 —OR*; —N(R*)—SO 2 —R*; —SO 2 —N(R*) 2 ; —O—SO 3 − ; —O—S(═O) 2 —OR*; —O—S(═O)—OR*; —O—S(═O)—R*; —S(═O)—OR*; —S(═O)—R*; —NO; —NO 2 ; —NO 3 ; —O—NO; —O—NO 2 ; —N 3 ; —N 2 —R*; —N(C 2 H 4 ); —Si(R*) 3 ; —CF 3 ; —O—CF 3 ; —PR* 2 ; —O—P(═O)(OR*) 2 ; —P(═O)(OR*) 2 ; perfluoroalkyl; an aliphatic C 1 -C 12 hydrocarbon radical; a C 1 -C 12 aromatic hydrocarbon radical; or a C 1 -C 12 heteroaryl radical; where R* is independently at each occurrence hydrogen or a branched, cyclic, or straight chained C 1 -C 20 hydrocarbon radical that is saturated, partially saturated, or aromatic, optionally substituted with 1-6 heteroatoms selected from nitrogen, oxygen, sulfur, or halogen;

R N is hydrogen or a saturated, partially saturated, or aromatic C 1 -C 20 hydrocarbon radical, optionally substituted with 1-6 heteroatoms selected from nitrogen, oxygen, sulfur, or halogen;

and salts thereof,

for a time sufficient to improve the appearance of wrinkles and/or fine lines on said human skin.

2. The method of treatment according to claim 1 , wherein L is —CH 2 —, and Q is selected from:

where X is either an oxygen atom, a sulfur atom, or NR*, and R 6 and R 7 are independently selected from groups R as defined above.

3. The method of treatment according to claim 2 , where Q is a group:

4. The method of treatment according to claim 1 , wherein R N is hydrogen or methyl.

5. The method of treatment according to claim 1 , wherein the compound according to formula I(a) has the structure:

and salts thereof.

6. The method according to claim 1 , wherein said method comprises topically applying the composition to affected skin of an individual in need thereof, at least once daily for a period of at least four weeks.

7. The method according to claim 1 , wherein said method comprises topically applying the composition to affected skin of an individual in need thereof, at least once daily for a period of at least eight weeks.

8. A method for treating wrinkles and/or fine lines on human skin comprising topically applying to an area of the skin in need thereof a topical composition comprising a cosmetically acceptable vehicle and an effective amount of a compound having the structure:

and cosmetically acceptable salts thereof, for a time sufficient to improve the aesthetic appearance of said human skin.

9. The method according to claim 8 , wherein said method comprises topically applying the composition to affected skin of an individual in need thereof, at least once daily for a period of at least four weeks.

10. The method according to claim 9 , wherein said composition is topically applied to affected skin of an individual in need thereof at least once daily for a period of at least eight weeks.

11. The method according to claim 9 , wherein said composition further comprises a retinoid.

12. The method according to claim 9 , wherein said composition further comprises an alpha-hydroxy acid and/or a beta-hydroxy acid.

13. A method for enhancing the production of collagen in human skin comprising topically applying to an area of the skin in need thereof a topical composition comprising a cosmetically acceptable vehicle, and an effective amount of a compound having the structure:

and cosmetically acceptable salts thereof.

14. The method according to claim 13 , wherein said composition further comprises a retinoid.

15. The method according to claim 13 , wherein said composition further comprises glycolic acid and/or salicylic acid.

16. The method according to claim 13 , wherein said composition is applied to said skin at least once daily for a period of at least four weeks.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2024
From: NATURA &CO HOLDING S.A.; NATURA COSMETICOS S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.A R.L. - LUXEMBOURG; NATURA &CO UK HOLDINGS LIMITED - UK
To: AVON PRODUCTS, INC
Reel/Frame 069591/0494 →
PATENT SECURITY AGREEMENT Recorded Aug 16, 2024
From: AVON PRODUCTS, INC.
To: NATURA &CO HOLDING S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L.; NATURA COSMÉTICOS S.A.; NATURA &CO UK HOLDINGS LIMITED
Reel/Frame 068659/0915 →
SECURITY INTEREST Recorded Nov 14, 2019
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A., LONDON BRANCH
Reel/Frame 051032/0210 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Aug 15, 2016
From: CITIBANK, N.A.
To: AVON PRODUCTS, INC.
Reel/Frame 039690/0331 →
SECURITY INTEREST Recorded Jun 12, 2015
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A.
Reel/Frame 035899/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2013
From: SANTHANAM, UMA; KHUSIAL, PERMANAN RAAJ
To: AVON PRODUCTS, INC.
Reel/Frame 029583/0596 →